Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Thursday, March 19, 2015

Australia: More Australians with Hepatitis C hope new drugs will be approved by Pharmaceutical Benefits Scheme

Nearly 250,000 Australians with Hepatitis C hope new drugs will be approved by the Pharmaceutical Benefits Scheme (PBS). 

Current medication can require 6-12 months of treatment and for many patients causes debilitating side effects like nausea, hair loss and depression.

Hepatitis Queensland spokeswoman Jodie Walton said while the available drugs had an 80 per cent cure rate, the emotional and physical cost was often too high.

She said the stigma associated with Hepatitis C meant many sufferers were reluctant to tell their family or work colleagues they were infected.

Read more...

No comments:

Post a Comment